Status:
RECRUITING
PCOM2 - The Physician Communication Intervention, Version 2.0
Lead Sponsor:
University of Colorado, Denver
Collaborating Sponsors:
University of Kansas Medical Center
San Diego State University
Conditions:
HPV Infection
Preventive Health Services
Eligibility:
All Genders
9-17 years
Phase:
NA
Brief Summary
Poor quality of primary care providers' vaccine recommendations lead to low adolescent human papillomavirus vaccination rates and hundreds of thousands of adolescents unnecessarily at risk for HPV-ass...
Detailed Description
The overarching goal is to develop a "Virtual" version of the PCOM intervention ("PCOM-Virtual") and compare its efficacy for increasing HPV vaccination among adolescents to that of the original PCOM ...
Eligibility Criteria
Inclusion
- Parents: Have an adolescent between the ages of 9-17 years old and receiving adolescent care at an enrolled clinic
- Providers: All providers at participating study practices will be eligible to participate.
Exclusion
- Parents: Does not have an adolescent between the ages of 9-17 years old and is not receiving adolescent care at an enrolled clinic
- Providers: Providers who are not at participating study practices
Key Trial Info
Start Date :
November 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05336240
Start Date
November 15 2023
End Date
December 31 2026
Last Update
August 26 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States, 80045
2
University of Kansas Medical Center
Wichita, Kansas, United States, 67208